Souhaitez-vous accéder aux communiqués récents ?

Key findings from the DME AWARE initiative highlight the importance of non-invasive treatment options for early intervention in diabetic macular edema (DME) managementOculis is on track to report...

Latest findings from the DME AWARE Delphi Study on unmet needs in diabetic macular edema (DME) management highlighting the need for non-invasive therapeutic options to be presented by Baruch...

Fort Lauderdale, FL, April 09, 2026 (GLOBE NEWSWIRE) -- The presence of microplastics and nanoplastics (MNPs) in the human heart has been gaining attention in recent years. A study back in 2024...

Fort Lauderdale, FL, March 31, 2026 (GLOBE NEWSWIRE) -- March is National Nutrition Month. As part of the ongoing focus on nutrition, Anathapindika is shining a spotlight on the growing awareness...

PRIME designation follows recent Breakthrough Therapy designation from the U.S. FDA, underscoring the importance and urgency of addressing optic neuritis, a serious condition that can have negative...

ZUG, Switzerland, 16 March, 2026 -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (Oculis), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical...

GRF partners with Alcon to launch Spanish glaucoma education resources, including the first Spanish audiobook, for Hispanic communities.

FORT LAUDERDALE, FL, March 06, 2026 (GLOBE NEWSWIRE) -- Sleep is a physiological requirement, and World Sleep Day emphasizes the importance of getting the right amount and quality of sleep. While...

FORT LAUDERDALE, FL, March 06, 2026 (GLOBE NEWSWIRE) -- February 28th is Rare Diseases Day. The observance helps shed light on thousands of underaddressed conditions across the United States and...

ZUG, Switzerland, March 05, 2026 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on innovations addressing...